Canada Markets closed

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
8.47+0.16 (+1.93%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close8.31
Open8.40
Bid8.39 x 1800
Ask8.49 x 3100
Day's Range8.19 - 8.52
52 Week Range7.23 - 11.55
Volume10,449,218
Avg. Volume9,047,208
Market Cap9.342B
Beta (5Y Monthly)1.22
PE Ratio (TTM)12.83
EPS (TTM)0.66
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateNov 27, 2017
1y Target Est11.36
  • Reuters

    UPDATE 3-Teva, Allergan reach $161.5 mln opioid settlement with West Virginia

    Teva Pharmaceutical Industries and AbbVie's Allergan unit reached a settlement worth $161.5 million to resolve claims the companies fueled an opioid epidemic in West Virginia, state attorney general Patrick Morrisey said on Wednesday. The agreement is the largest state-negotiated settlement in West Virginia history, and consists of $134 million in cash plus the contribution of drugs used to treat opioid overdoses, Morrisey said at a news conference.

  • Reuters

    Teva, Allergan reach $161.5 million opioid settlement with West Virginia

    (Reuters) -Teva Pharmaceutical Industries and AbbVie's Allergan unit reached a settlement worth $161.5 million to resolve claims the companies fueled an opioid epidemic in West Virginia, state attorney general Patrick Morrisey said Wednesday. The agreement is the largest state-negotiated settlement in West Virginia history, and consists of $134 million in cash plus the contribution of drugs used to treat opioid overdoses, Morrisey said. "This is a great day for West Virginia," Morrisey said at a press conference.

  • Business Wire

    Teva Reaches Agreement With West Virginia to Settle the State’s Opioid-Related Claims

    TEL AVIV, Israel & PARSIPPANY, N.J., May 25, 2022--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and its affiliates, has reached an agreement with the Attorney General of West Virginia that settles the state’s and its subdivisions opioid-related claims. The settlement will provide West Virginia with $75 million over 15 years in addition to $8 million in attorneys’ fees and costs incurred during the trial. Teva will also provide its life-savin